AAX Biotech is attending BIO-Europe Spring 2024

Written By Maria L Knudsen

AAX Biotech is looking forward to attending BIO-Europe Spring, March 18-20, 2024 in Barcelona, Spain! Reach out to CEO Maria Lisa Knudsen to discuss collaboration opportunities for our two unique technologies for accelerating drug discovery: 

  • Seqitope™: High resolution, high throughput epitope mapping

  • Opti-mAb™: A new scFv format for various applications including bispecific antibodies, CAR-T cell therapy, etc.

Event link

Maria L Knudsen
Previous

Svante Almkvist Appointed Chairman of the Board at AAX Biotech
Next

AAX Biotech pitching and showcasing at The Tech Arena 2024